A multi-institutional team led by The University of Osaka developed a chimeric antigen receptor (CAR) T cell-based strategy ...

The Da Nang Hospital announced on March 31 that its department of neurology – musculoskeletal – clinical hematology has ...

Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

Acute myeloid leukemia (AML) remains incurable for the majority of patients. AML originates from a rare population of cells, termed leukemic stem cells (LSCs) or leukemia-initiating cells ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune reaction in patients with several types of blood cancer.

Neural Stem Cell Transplantation Shows Promise for Treating ... Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive map ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.

5, 2024 — Stem cell transplantation is used to ... influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

Shanghai is setting a new weekly record with eight people donating stem cells this week. By Friday, Shanghai will have ...

Jeremiah Craft, a performing arts teacher at Great Oaks Legacy Charter School in Newark, said he became a stem cell donor ...

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies ...